Peripheral artery structure and endothelial function in heart failure: Effect of ACE inhibition

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 271, Issue 2 40-2, 1996, Pages

  Mulder, Paul ^a   Elfertak, Lahcen ^a   Richard, Vincent ^a   Compagnon, Patricia ^a   Devaux, Bruno ^a   Henry, Jean Paul ^a   Scalbert, Elizabeth ^a   Desché, Pierre ^a   Macé, Bertrand ^a   Thuillez, Christian ^a,b  

^a UNIVERSITÉ DE ROUEN   (France)

^b ROUEN UNIVERSITY HOSPITAL   (France)

Author keywords

cardiovascular structure; endothelial dysfunction

Indexed keywords

ACETYLCHOLINE; COLLAGEN; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; PERINDOPRIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTERY DILATATION; ARTERY ENDOTHELIUM; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ENZYME INHIBITION; FEMORAL ARTERY; HEART FAILURE; HEMODYNAMICS; MALE; MESENTERIC ARTERY; NONHUMAN; PRIORITY JOURNAL; RAT; VASOCONSTRICTION;

EID: 33750724799     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.1996.271.2.h469     Document Type: Article

References (29)

1. Anversa, P., C. Beghi, Y. Kikkawa, and G. Olivetti. Myocardial infarction in rats. Infarct size, myocyte hypertrophy and capillary growth. Circ. Res. 58: 26-37, 1986.
2. Arnal, J. R, C. Schott, J. C. Stoclet, and J. B. Michel. Vascular relaxation and cyclic guanosine monophosphate in a rat model of high output failure. Cardiovasc. Res. 27: 1651-1656, 1993.
3. DeFelice, A., A. Harris, R. Frering, and P. Horan. Beneficial hemodynamic effects of milrinone and enalapril in conscious rats with healed myocardial infarction. Eur. J. Pharmacol. 167: 211-220, 1989.
4. Dohi, Y., M. A. Thiel, F. R. Bühler, and T. F. Lüscher. Activation of endothelial L-arginine pathway in resistance arteries. Effect of age and hypertension. Hypertension Dallas 15: 170-179, 1990.
5. Drexler, H., D. Hayoz, T. Münzel, A. M. Zeiher, B. Horning, H. Just, H. R. Brunner, and R. Zelis. Characterization of endothelial function in patients with chronic heart failure. N. Engl. J. Med. 316: 1429-1435, 1987.
6. Drexler, H., and L. Wenyan. Endothelial dysfunction of hind-quarter resistance vessels in experimental heart failure. Am. J. Physiol. 262 (Heart Circ. Physiol. 31): H1640-H1645, 1992.
7. Flavahan, N. A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation 85: 1927-1938, 1992.
8. Fletcher, P. J., J. M. Pfeffer, M. A. Pfeffer, and E. Braunwald. Left ventricular diastolic pressure-volume relations in rats with healed myocardial infarction. Effects on systolic function. Circ. Res. 49: 618-626, 1981.
9. Gay, R. G. Early and late effects of captopril treatment after large myocardial infarction in rats. J. Am. Coll. Cardiol. 16: 967-977, 1990.
10. Halpern, W., and M. Kelley. In vitro methodology for resistance arteries. Blood Vessels 28: 245-251, 1991.
11. Katz, S. D., L. Biasucci, C. Sabba, J. A. Strom, G. Jondeau, M. Galvao, S. Solomon, S. D. Nikiolic, R. Forman, and T. H. LeJemtel. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J. Am. Coll. Cardiol. 19: 918-925, 1992.
12. Kubo, S. H., T. S. Rector, A. J. Bank, R, E. Williams, and S. M. Heifetz. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation 84: 1589-1596, 1991.
13. LeJemtel, T. H., C. S. Maskin, D. Lucido, and B. J. Chadwick. Failure to augment maximal limb blood flow in response to one-leg versus two-leg exercise in patients with severe heart failure. Circulation 74: 245-251, 1986.
14. Michel, J. B., D. Heudes, O. Michel, P. Poitevin, M. Phillippe, E. Scalbert, B. Corman, and B. Levy. Effect of chronic ANG I-converting enzyme inhibition on aging processess. II. Large arteries Am. J. Physiol. 267 (Regulatory Integrative Comp. Physiol. 36): R124-R135, 1994.
15. Michel, J. B., A. L. Lattion, J. L. Salzman, M. L. Cerol, M. Philippe, J. P. Camilleri, and P. Corvol. Hormonal and cardiac effects of converting enzyme inhibition in rat myocardial infarction. Circ. Res. 62: 641-650, 1988.
16. Miller, V. M., and P. M. Vanhoutte. Enhanced release of endothelium-derived factor(s) by chronic increases in blood flow. Am. J. Physiol. 255 (Heart Circ. Physiol. 24): H446-H451, 1988.
17. Ontkean, M., R. Gay, and B. Greenberg. Diminished endothelium-derived relaxing factor activity in an experimental model of chronic heart failure. Circ. Res. 69: 1088-1096, 1991.
18. Pearson, P. J., H. V. Schaff, and P. M. Vanhoutte. Long-term impairment of endothelium-dependent relaxations to aggregating platelets after reperfusion injury in canine coronary arteries. Circulation 81: 1921-1927, 1990.
19. Pfeffer, J. M., M. A. Pfeffer, and E. Braunwald. Influence of chronic captopril therapy on the infarcted left ventricle of the rat. Circ. Res. 57: 84-95, 1985.
20. Pfeffer, M. A., J. M. Pfeffer, M. C. Fishbein, P. J. Fletcher, J. Sparado, R. A. Kloner, and E. Braunwald. Myocardial infarct size and ventricular function in rats. Circ. Res. 44: 503-512, 1979.
21. Pfeffer, M. A., J. M. Pfeffer, C. Steinberg, and P. Finn. Survival after an experimental myocardial infarction, beneficial effects of long-term therapy with captopril. Circ. Res. 72: 406-412, 1985.
22. Richer, C., P. Mulder, P. Fornes, V. Domergue, D. Heudes, and J. F. Giudicelli. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats J. Cardiovasc. Pharmacol. 20: 147-156, 1992.
23. Sweet, C. S., C. T. Ludden, I. I. Stabilito, S. E. Emmert, and J. F. Heyse. Beneficial effects of milrinone and enalapril on long-term survival of rats with healed myocardial infarction. Eur. J. Pharmacol. 147: 29-37, 1988.
24. Teerlink, J. R., M. Clozel, W. Fischli, and J. P. Clozel. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J. Am. Coll. Cardiol. 22: 610-620, 1993.
25. Thuillez, C., C. Richard, H. Loueslati, P. Auzepy, and J. F. Giudicelli. Systemic and regional hemodynamic effects of perindopril in congestive heart failure. J. Cardiovasc. Pharmacol. 15: 527-535, 1990.
26. Weber, K. T., and C. G. Brilla. Pathological hypertrophy and cardiac interstitium. Circ. Res. 83: 1849-1865, 1991.
27. Wilson, J. R., J. M. Martin, D. Schwartz, and N. Ferraro. Exercise tolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle. Circulation 69: 1079-1087, 1984.
28. Wollert, K. C., R. Studer, H. Just, and H. Drexler. Influence of lisinopril on long-term mortality in rats with chronic myocardial infarction: role of blood pressure reduction and tissue ACE inhibition. Circulation 90: 2457-2467, 1994.
29. Zelis, R., and D. T. Mason. Compensatory mechanisms in congestive heart failure. The role of peripheral vessels. N. Engl. J. Med. 282: 962-964, 1970.